EyePoint Inc.

Last updated September 27, 2026

Organization details

Legal name
EyePoint Inc.
Former names
EyePoint Pharmaceuticals, Inc. pSivida Corp.
Ownership
Public
Status
Active
Sector (GICS)
Information Technology
SIC code
3826 — Laboratory Analytical Instruments
Jurisdiction of incorporation
Delaware
Headquarters city
Watertown
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
EYPT
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001314102
EIN
26-2774444
Wikidata ID
Q7120927

Board of directors

Chief executives

Nancy Lurker · CEO
Dates unknown
Jay S. Duker · President and CEO
Dates unknown

Board connections

6 of this board's directors also sit on 12 other boards.

Network of EyePoint Inc.'s board connections Achieve Life Sciences Inc. Achieve Life Sciences... Alkermes plc Alkermes plc Axogen Inc. Axogen Inc. BridgeBio Pharma Inc. BridgeBio Pharma Inc. Cartesian Therapeutics Inc. Cartesian Therapeutics... Cocrystal Pharma Inc. Cocrystal Pharma Inc. Collegium Pharmaceutical Inc. Collegium Pharmaceutic... Foghorn Therapeutics Inc. Foghorn Therapeutics I... Kalaris Therapeutics Inc. Kalaris Therapeutics I... Milestone Pharmaceuticals Inc. Milestone Pharmaceutic... Precigen Inc. Precigen Inc. Recursion Pharmaceuticals Inc. Recursion Pharmaceutic... Anthony P. Adamis Anthony P. Adamis Fred Hassan Fred Hassan Goran Ando Goran Ando Karen L. Zaderej Karen L. Zaderej Nancy Lurker Nancy Lurker Stuart Duty Stuart Duty EyePoint Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$71,983
2 purchases by 2 insiders
Sold, last 12 months
$2,010,341
10 sales by 3 insiders
Date Insider Transaction Shares Price Value
Aug 20, 2026 Elston George Officer (Chief Financial Officer) Other −5,000 — —
Aug 20, 2026 Elston George Officer (Chief Financial Officer) Other +5,000 — —
Aug 20, 2026 Elston George Officer (Chief Financial Officer) Gift −64,953 — —
Aug 20, 2026 Elston George Officer (Chief Financial Officer) Gift +64,953 — —
Aug 18, 2026 Karen L. Zaderej Director Open-market purchase +10,600 $4.93 $52,258
Jul 10, 2026 Jay S. Duker Director, Officer (President and CEO) Option exercise +16,667 — —
Jul 10, 2026 Jay S. Duker Director, Officer (President and CEO) Shares withheld for tax −8,059 $14.72 $118,628
Jun 30, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Option exercise +2,437 $8.26 $20,130
Jun 30, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Option exercise +2,438 $8.26 $20,138
Jun 30, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Open-market sale −2,437 $15.00 $36,555
Jun 30, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Open-market sale −2,438 $15.02 $36,619
May 25, 2026 Elston George Officer (Chief Financial Officer) Option exercise +7,500 — —
May 25, 2026 Elston George Officer (Chief Financial Officer) Shares withheld for tax −3,627 $12.93 $46,897
Apr 17, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Option exercise +2,437 $8.26 $20,130
Apr 17, 2026 Ribeiro Ramiro Officer (Chief Medical Officer) Open-market sale −2,437 $15.00 $36,555

Organizations in the same sector, closest in location and size first.

Questions about EyePoint Inc.

Who is the CEO of EyePoint Inc.?

Nancy Lurker is EyePoint Inc.'s CEO.

How many directors are on EyePoint Inc.'s board?

EyePoint Inc.'s board has 13 directors: Anthony P. Adamis, David R. Guyer, Fred Hassan, Goran Ando, Jay S. Duker, John B. Landis, Karen L. Zaderej, Nancy Lurker, Reginald J. Sanders, Stuart Duty and 3 others.

Are EyePoint Inc. insiders buying or selling shares?

Over the last 12 months, EyePoint Inc. insiders bought $71,983 of shares in 2 purchases and sold $2.0 million of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="eyepoint-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.